81 filings
8-K
VERV
Verve Therapeutics Inc
28 Jun 24
Departure of Directors or Certain Officers
7:47am
8-K/A
VERV
Verve Therapeutics Inc
28 Jun 24
Submission of Matters to a Vote of Security Holders
7:44am
8-K
VERV
Verve Therapeutics Inc
7 Jun 24
Submission of Matters to a Vote of Security Holders
4:07pm
8-K
VERV
Verve Therapeutics Inc
31 May 24
Departure of Directors or Certain Officers
7:14am
10-Q
2024 Q1
VERV
Verve Therapeutics Inc
Quarterly report
8 May 24
7:30am
8-K
z3c79tmnb9qwb47i1
8 May 24
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
7:15am
ARS
xtgm iio9v
26 Apr 24
Annual report to shareholders
7:59am
DEFA14A
5xh yinzymoih044qx
26 Apr 24
Additional proxy soliciting materials
7:56am
8-K
hjkfuvaw
2 Apr 24
Other Events
7:13am
S-8
47zxx9
27 Feb 24
Registration of securities for employees
8:32am
8-K
4j37153q
27 Feb 24
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
7:45am
8-K
fb4tp494 3665
29 Nov 23
Verve Therapeutics Announces Pricing of Public Offering of Common Stock and Concurrent Private Placement
4:54pm
424B5
eh4je9l
29 Nov 23
Prospectus supplement for primary offering
4:47pm
424B5
q75 l00bzzmef8m3154c
28 Nov 23
Prospectus supplement for primary offering
4:25pm
8-K
4bgw81e
13 Nov 23
Other Events
6:34am
8-K
ivryf0fr
7 Nov 23
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
7:00am
8-K
spv2kzlu ju
23 Oct 23
Other Events
6:41am